These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 17942608

  • 1. Induction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach.
    Li W, Guentzel MN, Seshu J, Zhong G, Murthy AK, Arulanandam BP.
    Clin Vaccine Immunol; 2007 Dec; 14(12):1537-44. PubMed ID: 17942608
    [Abstract] [Full Text] [Related]

  • 2. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
    Murthy AK, Chambers JP, Meier PA, Zhong G, Arulanandam BP.
    Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987
    [Abstract] [Full Text] [Related]

  • 3. Intranasal immunization with recombinant chlamydial protease-like activity factor attenuates atherosclerotic pathology following Chlamydia pneumoniae infection in mice.
    Li W, Gudipaty P, Li C, Henderson KK, Ramsey KH, Murthy AK.
    Immunol Cell Biol; 2019 Jan; 97(1):85-91. PubMed ID: 30051926
    [Abstract] [Full Text] [Related]

  • 4. Vaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.
    Tifrea DF, Ralli-Jain P, Pal S, de la Maza LM.
    Infect Immun; 2013 May; 81(5):1741-50. PubMed ID: 23478318
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antigen-specific CD4+ T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection.
    Li W, Murthy AK, Guentzel MN, Seshu J, Forsthuber TG, Zhong G, Arulanandam BP.
    J Immunol; 2008 Mar 01; 180(5):3375-82. PubMed ID: 18292563
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.
    Brown TH, David J, Acosta-Ramirez E, Moore JM, Lee S, Zhong G, Hancock RE, Xing Z, Halperin SA, Wang J.
    Vaccine; 2012 Jan 05; 30(2):350-60. PubMed ID: 22075089
    [Abstract] [Full Text] [Related]

  • 10. Intranasal vaccination with Chlamydia pneumoniae induces cross-species immunity against genital Chlamydia muridarum challenge in mice.
    Manam S, Chaganty BK, Evani SJ, Zafiratos MT, Ramasubramanian AK, Arulanandam BP, Murthy AK.
    PLoS One; 2013 Jan 05; 8(5):e64917. PubMed ID: 23741420
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele.
    Murthy AK, Cong Y, Murphey C, Guentzel MN, Forsthuber TG, Zhong G, Arulanandam BP.
    Infect Immun; 2006 Dec 05; 74(12):6722-9. PubMed ID: 17015458
    [Abstract] [Full Text] [Related]

  • 13. The cationic liposomal adjuvants CAF01 and CAF09 formulated with the major outer membrane protein elicit robust protection in mice against a Chlamydia muridarum respiratory challenge.
    Pal S, Tifrea DF, Follmann F, Andersen P, de la Maza LM.
    Vaccine; 2017 Mar 23; 35(13):1705-1711. PubMed ID: 28238632
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge.
    Pal S, Favaroni A, Tifrea DF, Hanisch PT, Luczak SET, Hegemann JH, de la Maza LM.
    Vaccine; 2017 May 02; 35(19):2543-2549. PubMed ID: 28385608
    [Abstract] [Full Text] [Related]

  • 15. Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection.
    Cong Y, Jupelli M, Guentzel MN, Zhong G, Murthy AK, Arulanandam BP.
    Vaccine; 2007 May 10; 25(19):3773-80. PubMed ID: 17349723
    [Abstract] [Full Text] [Related]

  • 16. Vaccination with the defined chlamydial secreted protein CPAF induces robust protection against female infertility following repeated genital chlamydial challenge.
    Murthy AK, Li W, Guentzel MN, Zhong G, Arulanandam BP.
    Vaccine; 2011 Mar 21; 29(14):2519-22. PubMed ID: 21300093
    [Abstract] [Full Text] [Related]

  • 17. A T cell epitope-based vaccine protects against chlamydial infection in HLA-DR4 transgenic mice.
    Li W, Murthy AK, Lanka GK, Chetty SL, Yu JJ, Chambers JP, Zhong G, Forsthuber TG, Guentzel MN, Arulanandam BP.
    Vaccine; 2013 Nov 19; 31(48):5722-8. PubMed ID: 24096029
    [Abstract] [Full Text] [Related]

  • 18. Vaccination with the polymorphic membrane protein A reduces Chlamydia muridarum induced genital tract pathology.
    Müller T, Becker E, Stallmann S, Waldhuber A, Römmler-Dreher F, Albrecht S, Mohr F, Hegemann JH, Miethke T.
    Vaccine; 2017 May 15; 35(21):2801-2810. PubMed ID: 28413133
    [Abstract] [Full Text] [Related]

  • 19. A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge.
    Pal S, Tatarenkova OV, de la Maza LM.
    Immunology; 2015 Nov 15; 146(3):432-43. PubMed ID: 26423798
    [Abstract] [Full Text] [Related]

  • 20. The duration of Chlamydia muridarum genital tract infection and associated chronic pathological changes are reduced in IL-17 knockout mice but protection is not increased further by immunization.
    Andrew DW, Cochrane M, Schripsema JH, Ramsey KH, Dando SJ, O'Meara CP, Timms P, Beagley KW.
    PLoS One; 2013 Nov 15; 8(9):e76664. PubMed ID: 24073293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.